Moderna, Inc.
MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30573% above fair value
$220.83−0.89 (-0.40%)
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna Norwood, Massachusetts manufacturing & technical by Year
Norwood, Massachusetts manufacturing & technical development campus (sq ft)
Moderna Norwood, Massachusetts manufacturing & technical: 722,000.00 sqft in FY2025, unchanged from a year earlier.
Latest, FY2025
722,000.00
Period ended Dec 31, 2025
Change on a year earlier
0.0%
722,000.00 in FY2024
History
3 years
Since FY2023
Sources
3
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-20) ↗
Reported in Form 10-Q / 10-K Note 10 (Leases).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Norwood, Massachusetts manufacturing & technical development campus (sq ft) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 722,000.00 | 0.0% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 722,000.00 | +5.2% | Form 10-K (filed 2025-02-21) ↗ |
| FY2023 | Dec 31, 2023 | 686,000.00 | – | Form 10-K (filed 2024-02-23) ↗ |
Cite this data
StockData. (2026). Moderna Norwood, Massachusetts manufacturing & technical, annual FY2023–FY2025 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/realestate-norwood-sqft
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.